How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform

Positive

AI Analysis

Summary

ConcertAI acquired CancerLinQ from ASCO, transforming the platform into a point-of-care oncology intelligence system that pools electronic health record data from oncology practices for learning and clinical decision support.

Importance:4/10

Sentiment:

0.50

acquisitiononcologyAIreal-world dataCancerLinQelectronic health records

Related Companies

$ATALF

Read the original article

Published by Drug Discovery & Development on July 8, 2026 9:38 PM

Read Original